FLT3-TKD mutations represent 47.4% (9/19) of the FLT3POS cases, and 11.25% (9/80) of the total of patients, a higher prevalence than the 7.7% reported for AML adult patients (35). Here, FLT3 is linked to acute myeloid leukemia.